发明名称 HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
摘要 PROBLEM TO BE SOLVED: To provide human protein tyrosine phosphatase inhibitors and to provide methods of use.SOLUTION: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-&bgr;) inhibitors, thereby regulating angiogenesis. The present disclosure further relates to compositions comprising the human protein tyrosine phosphatase beta (HPTP-&bgr;) inhibitors, and to methods for regulating angiogenesis. Disorders treated by the compounds of this invention includes diabetic retinopathy, macular degeneration, cancer, sickle cell anemia, sarcoid, syphilis, pseudoxanthoma elasticum, Paget's disease, vein occlusion, artery occlusion, carotid obstructive disease, chronic uveitis/vitritis, mycobacterial infections, and the like.
申请公布号 JP2015221837(A) 申请公布日期 2015.12.10
申请号 JP20150178321 申请日期 2015.09.10
申请人 AERPIO THERAPEUTICS INC 发明人 GRAY JEFFREY LYLE;AMARASINGHE KANDE;CLARK CYNTHIA MONESA;MAIER MATHEW BRIAN;NICHOLS RYAN
分类号 C07D277/28;A61K31/426;A61K31/427;A61K31/538;A61P1/04;A61P7/06;A61P9/00;A61P9/10;A61P15/00;A61P17/06;A61P19/02;A61P27/02;A61P29/00;A61P31/00;A61P31/04;A61P33/02;A61P35/00;A61P37/02;A61P43/00;C07D277/48;C07D417/04;C07D417/12;C07D417/14 主分类号 C07D277/28
代理机构 代理人
主权项
地址